U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07341893) titled 'Sacubitril-valsartan in Patients With Heart Failure.' on Jan. 01.
Brief Summary: The aim of this study is to evaluate the safety and efficacy of Sacubitril -Valsartan in patients with heart failure.
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Intervention:
DRUG: Sacubitril-valsartan
patients (n=30) will be given Sacubitril-valsartan 50 mg twice daily.
DRUG: standard treatment of heart failure
Control group (n=30) on standard treatment of heart failure.
Recruitment Status: RECRUITING
Sponsor: Damanhour University
Information provided by (Responsible Party): Rehab Werida, Damanhour U...